78% of patients with diabetes
surveyed are ‘very or somewhat likely’
to participate in a diabetes trial NOW.
Kickoff your access to diabetes patients
with a ridiculously short form.
Get started now
We connect you with diabetes patients.
SubjectWell has more than 470,000 patients diagnosed with type 2 diabetes currently active in our marketplace. And we have referred patients to over 200 trials requiring a diabetes diagnosis.
Voice of the diabetic patient.
In a SubjectWell survey of over 300 patients with type two diabetes:
2-6% higher interest in trial participation from patients with the secondary conditions anxiety, neuropathy, or gum disease.
89% of Black and Hispanic patients reported high interest in trial participation when compensation was included.
Uncover interesting diabetes patient trends in the complete survey results.
Want to see how we work?
Give us two weeks and a look at your protocol, and we’ll complete a risk-free patient recruitment assessment using real-world data to determine our enrollment impact. Here’s a sample diabetes assessment showing the types of data we’ll compile on your unique study.